Lung Diseases, Obstructive: Clinical Trials

937 trials for Lung Diseases, Obstructive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

643 completed, 114 unknown, 67 terminated, 43 withdrawn. 937 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4937Completed 643, Unknown 114, Terminated 67, Withdrawn 43, Recruiting 34, Not yet recruiting 18, Active not recruiting 15, Enrolling by invitation 3

Follow Lung Diseases, Obstructive: new trials by email Literature Review of Lung Diseases, Obstructive trials Research Report on Lung Diseases, Obstructive

Trials (filtered) newest first · largest first

All 937 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RSV Vaccination to Reduce Recurrent AECOPD
RSV vaccination (Arexvy, GlaxoSmithKline) - COPD, RSV
Phase 4Not yet recruitingChinese University of Hong Kong3202027-07-012026-04-13
Prevent Wheeze Trial
Dexamethasone 0.6 mg/kilogram body weight single dose, Placebo - Lower Respiratory Tract Infection (LRTI), Recurrent Wheezing
Phase 4Not yet recruitingNorwegian University of Science and Technology4862027-02-012026-10-05
Comparative Effectiveness of Roflumilast and Azithromycin in Reducing Exacerbations in Severe Chronic Obstructive Pulmonary Disease ( COPD ) Patients With Chronic Bronchitis Phenotype
Roflumilast Oral Tablet, Azithromycin 250 mg - Chronic Obstructive Pulmonary Disease With Exacerbation
Phase 4Not yet recruitingSidra Aziz702027-02-012026-08-31
The LalelaLung Study: Digital Stethoscope Clinical Evaluation
StethoMe AI-enabled digital stethoscope system, Standard IMCI assessment - Pneumonia, Tuberculosis, Pulmonary
Phase 4Not yet recruitingJohns Hopkins University3502026-12-072026-11-10
Effect of add-on Doxofylline on Lung Function in Stable COPD
Doxofylline - Chronic Obstructive Pulmonary Disease
Phase 4Not yet recruitingUniversity of Milan782026-12-012026-04-29
A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above, With Chronic Graft-versus-host Disease (cGVHD)
Belumosudil - Chronic Graft Versus Host Disease
Phase 4Not yet recruitingSanofi262026-11-202026-11-10
Novel Method for Removal of Orally Deposited Inhaled Fluticasone Propionate
Fluticasone Propionate, Water Mouthwash, EVOOW Mouthwash - Asthma
Phase 4Not yet recruitingUniversity of Wisconsin, Madison202026-11-012026-11-05
This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization
dupilumab, Placebo - Chronic Obstructive Pulmonary Disease (COPD)
Phase 4RecruitingRegeneron Pharmaceuticals7542026-10-062026-10-16
Airway Dysfunction, Occlusions and Remodeling: COPD Patients and Mepolizumab
Mepolizumab 100 MG Injection - COPD (Chronic Obstructive Pulmonary Disease)
Phase 4Not yet recruitingWestern University, Canada362026-10-012026-08-06
Study to Evaluate the Effects of Oral Glyceryl Guiacolate (Guaifenesin, GGE) on Sputum Rheology in Subjects With Mucus Hypersecretion
Glycerol Guiacolate, SOC (Standard of care) - Bronchitis, Bronchitis, Chronic
Phase 4Not yet recruitingUniversity of North Carolina, Chapel Hill402026-10-012026-10-14
Evaluation of ALLERgen Specific Vaccination of DOG Allergic Patients in Swedish Practice
ALK Alutard SQ Dog - Allergic Rhinitis, Asthma (Diagnosis)
Phase 4RecruitingKarolinska Institutet402026-08-012026-06-29
Giving Asthmatics Intramuscular Steroids for Preventing Return to the Emergency Department
Dexamethasone 16mg IM, Prednisone 60mg PO - Asthma
Phase 4RecruitingMontefiore Medical Center1822026-07-232026-07-24
Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD
Nebulized therapy of similar medication solutions, Continue handheld therapy - COPD (Chronic Obstructive Pulmonary Disease), Chronic Obstructive Pulmonary Disease (COPD)
Phase 4RecruitingCOPD Foundation1202026-07-142026-09-14
Fasenra: An Asthma Study
Budesonide-albuterol, Benralizumab - Eosinophilic Asthma, Severe Asthma
Phase 4Enrolling by invitationEndeavor Health402026-07-012026-09-15
BETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg])
Beclometasone dipropionate, formoterol fumarate, and glycopyrronium bromide (100/6/12.5 µg per actuation), Foster® 200/6 pMDI (BDP/FF-200/6 µg) - Asthma
Phase 4RecruitingChiesi Farmaceutici S.p.A.6442026-06-282026-07-31
Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aP
Anrikefon, Nalfurafine - Pruritus Chronic, Kidney Diseases, Chronic
Phase 4RecruitingZhujiang Hospital502026-06-222026-08-25
Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA)
Tezepelumab, Placebo - Severe Asthma
Phase 4RecruitingUniversity of Alberta1002026-05-112026-07-17
Ventilation and Perfusion in Asthmatics
Albuterol Sulfate, Albuterol-Budesonide - Asthma
Phase 4RecruitingUniversity of Miami402026-04-272026-10-23
129-Xe MRI Study of Single Triple Therapy Inhaler Effects in COPD Patients With Moderate-severe Dyspnea and/or Poor Health Status With High or Low Risk of Exacerbation
fluticasone furoate(FF)/umeclidinium (UMEC)/vilanterol(VI) (100/62.5/25) mcg - Chronic Obstructive Pulmonary Disease (COPD)
Phase 4RecruitingWestern University, Canada602026-04-242026-07-31
Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)
Methylprednisolone (drug), Hydrocortisone - Chronic Obstructive Pulmonary Disease (COPD)
Phase 4RecruitingCopenhagen Respiratory Research20002026-03-102026-03-18

Showing 20 of 937. Sign in to see all of them.

Narrower conditions

Asthma (430)  ·  Pulmonary Disease, Chronic Obstructive (430)  ·  Bronchiolitis Obliterans Syndrome (53)  ·  Bronchitis, Chronic (33)  ·  Emphysema (30)  ·  Motor Activity (24)  ·  Bronchitis (23)  ·  Dyspnea (20)  ·  Bronchiolitis (17)  ·  Rhinitis, Allergic (17)  ·  Lung Diseases (16)  ·  Pulmonary Eosinophilia (15)  ·  Respiratory Sounds (14)  ·  Inflammation (12)

Broader conditions

Respiratory Tract Diseases (931)  ·  Lung Diseases (921)  ·  Bronchial Diseases (561)  ·  Pathological Conditions, Signs and Symptoms (511)  ·  Immune System Diseases (486)  ·  Pathologic Processes (473)  ·  Disease Attributes (461)  ·  Chronic Disease (450)  ·  Hypersensitivity, Immediate (435)  ·  Hypersensitivity (432)  ·  Respiratory Hypersensitivity (427)  ·  Infections (108)  ·  Bronchitis (106)  ·  Respiratory Tract Infections (88)

Interventions

Fluticasone (80)  ·  Tiotropium Bromide (75)  ·  Albuterol (65)  ·  Budesonide (65)  ·  Salmeterol Xinafoate (58)  ·  Formoterol Fumarate (55)  ·  montelukast (48)  ·  Fluticasone-Salmeterol Drug Combination (46)  ·  Budesonide, Formoterol Fumarate Drug Combination (26)  ·  Beclomethasone (24)  ·  Omalizumab (24)  ·  indacaterol (24)  ·  Ipratropium (21)  ·  Glycopyrrolate (20)  ·  Azithromycin (19)

Sponsors

GlaxoSmithKline (89)  ·  AstraZeneca (41)  ·  Boehringer Ingelheim (35)  ·  Novartis Pharmaceuticals (33)  ·  Organon and Co (19)  ·  University of Dundee (19)  ·  University of Zurich (13)  ·  University of Saskatchewan (12)  ·  Imperial College London (11)  ·  Sanofi (11)  ·  Medical University of Lodz (9)  ·  University of Milan (9)  ·  Centre of Chinese Medicine, Georgia (8)  ·  Zhujiang Hospital (8)  ·  Johns Hopkins University (7)

Countries

United States (270)  ·  Canada (99)  ·  United Kingdom (99)  ·  Germany (81)  ·  Spain (69)  ·  Italy (60)  ·  China (57)  ·  Denmark (54)  ·  Netherlands (53)  ·  Belgium (47)  ·  France (42)  ·  Poland (34)  ·  Sweden (33)  ·  Brazil (26)  ·  Turkey (Türkiye) (25)

Top investigators

Konrad E Bloch, MD (11)  ·  Talant M Sooronbaev, MD (10)  ·  Brian Lipworth, MD (6)  ·  Don Cockcroft, MD (6)  ·  Iwona Stelmach, MD, PhD, Prof (6)  ·  Manana Tchaia, MD (6)  ·  Merab Lomia, MD, PhD (6)  ·  Leslie Hendeles, PharmD (4)  ·  Tamara Tchelidze, MD (4)

Results publications

PMID 11019457, PMID 16322646, PMID 16799080, PMID 17310045, PMID 17951621, PMID 18625750, PMID 18804362, PMID 19897551, PMID 20167147, PMID 21428765, PMID 23613569, PMID 27883002, PMID 29763572, PMID 32298853, PMID 33369570, PMID 34433773, PMID 36472162, PMID 37347518, PMID 37536444, PMID 37952772, PMID 39756820, PMID 8810608, PMID 10109801, PMID 10430726, PMID 11113831, PMID 11377644, PMID 11401887, PMID 11491153, PMID 11549531, PMID 11825832, PMID 12045120, PMID 12095178, PMID 12114338, PMID 12204862, PMID 12570114, PMID 12612294, PMID 15229100, PMID 15539711, PMID 15591470, PMID 15764761, PMID 15823451, PMID 15922813, PMID 15955146, PMID 16055868, PMID 16055882, PMID 16113473, PMID 16135736, PMID 16144890, PMID 16157462, PMID 16203030

NIH funding

2017 (15), 2019 (11), 2015 (10), 2014 (8), 2016 (6), 2025 (6), 2018 (4), 2023 (4), 2005 (2), 2008 (2), R01AT007987 (2), 2009 (1), K23HL171940 (1), N01MH090003 (1), P01HL128191 (1)